Granite Point Capital Management, L.P. Gain Therapeutics, Inc. Transaction History
Granite Point Capital Management, L.P.
- $0
- Q3 2023
Shares
3 transactions
Others Institutions Holding GANX
# of Institutions
32Shares Held
2.32MCall Options Held
22.2KPut Options Held
16K-
David Einhorn Greenlight Capital Inc | New York, Ny588KShares$711,9760.1% of portfolio
-
Dme Capital Management, LP New York, NY566KShares$685,0170.1% of portfolio
-
Royal Bank Of Canada Toronto, A6249KShares$300,6850.0% of portfolio
-
Geode Capital Management, LLC Boston, MA177KShares$214,2800.0% of portfolio
-
Telemetry Investments, L.L.C. New York, NY123KShares$148,8300.61% of portfolio
About Gain Therapeutics, Inc.
- Ticker GANX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,883,400
- Market Cap $14.4M
- Description
- Gain Therapeutics, Inc., a biotechnology company, engages in developing various therapies to treat diseases caused by protein misfolding. It focuses on rare genetic diseases and neurological disorders. The company uses its Site-Directed Enzyme Enhancement Therapy platform to discover allosteric sites on misfolded proteins and identify proprietar...